|
US4287341A
(en)
*
|
1979-11-01 |
1981-09-01 |
Pfizer Inc. |
Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
|
|
US6723727B1
(en)
*
|
1996-12-20 |
2004-04-20 |
Hoechst Aktiengesellschaft |
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
|
|
EP0903344B1
(en)
*
|
1997-08-21 |
2011-01-26 |
Shiseido Co., Ltd. |
Quinazolin-4-one derivatives, their preparation and their use as hair growth promoters or in external compositions for skin
|
|
US6355637B1
(en)
|
1999-10-01 |
2002-03-12 |
Advanced Medicine, Inc. |
Local anesthetic compounds
|
|
GEP20084317B
(en)
|
2000-04-25 |
2008-02-25 |
Icos Corp |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
|
US6667300B2
(en)
*
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
AUPR201600A0
(en)
*
|
2000-12-11 |
2001-01-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivative
|
|
EP2329822A1
(en)
|
2001-09-05 |
2011-06-08 |
Minerva Biotechnologies Corporation |
Compositions and methods of treatment of cancer
|
|
WO2003020280A2
(en)
*
|
2001-09-05 |
2003-03-13 |
Minerva Biotechnologies Corporation |
Compositions and use thereof in the treatment of cancer
|
|
JP2005511581A
(ja)
*
|
2001-11-07 |
2005-04-28 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害剤
|
|
AUPS019702A0
(en)
*
|
2002-01-29 |
2002-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Condensed heterocyclic compounds
|
|
WO2004018058A2
(en)
*
|
2002-08-21 |
2004-03-04 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
MXPA05004328A
(es)
*
|
2002-11-04 |
2005-08-02 |
Nps Pharma Inc |
Compuestos de quinazolinona como calciliticos.
|
|
EP1646615B1
(en)
*
|
2003-06-06 |
2009-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives as modulators of atp-binding cassette transporters
|
|
WO2005016348A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Method of inhibiting immune responses stimulated by an endogenous factor
|
|
US20050054614A1
(en)
*
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
|
WO2005113556A1
(en)
|
2004-05-13 |
2005-12-01 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
|
WO2005117889A1
(en)
*
|
2004-05-25 |
2005-12-15 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic
|
|
WO2006089106A2
(en)
*
|
2005-02-17 |
2006-08-24 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
|
EP2010505B1
(en)
*
|
2006-03-28 |
2012-12-05 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
KR20160091440A
(ko)
|
2008-11-13 |
2016-08-02 |
길리아드 칼리스토가 엘엘씨 |
혈액 종양에 대한 요법
|
|
BRPI1012333A2
(pt)
|
2009-03-24 |
2016-03-29 |
Gilead Calistoga Llc |
atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
|
|
AP2011005956A0
(en)
*
|
2009-04-20 |
2011-10-31 |
Gilead Calistoga Llc |
Methods of treatment for solid tumors.
|
|
CA2768843A1
(en)
|
2009-07-21 |
2011-01-27 |
Gilead Calistoga Llc |
Treatment of liver disorders with pi3k inhibitors
|
|
BRPI1003506B1
(pt)
|
2010-09-24 |
2019-12-03 |
Ache Int Bvi Ltd |
composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
|
|
EP2697206B1
(en)
|
2011-04-10 |
2019-04-03 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
NZ629684A
(en)
|
2012-03-05 |
2016-10-28 |
Gilead Calistoga Llc |
Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
|
|
ES2595240T3
(es)
|
2012-07-09 |
2016-12-28 |
Lupin Limited |
Derivados de tetrahidroquinazolinona como inhibidores de PARP
|
|
WO2015095605A1
(en)
|
2013-12-20 |
2015-06-25 |
Gilead Calistoga Llc |
Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one
|
|
NZ736970A
(en)
|
2013-12-20 |
2018-11-30 |
Gilead Calistoga Llc |
Process methods for phosphatidylinositol 3-kinase inhibitors
|
|
MA40059A
(fr)
|
2014-06-13 |
2015-12-17 |
Gilead Sciences Inc |
Inhibiteurs de la phosphatidylinositol 3-kinase
|